Table 1.
Demographic and clinical information of patients with type 2 diabetes mellitus (n = 143, otherwise as indicated)
| Variable | n (%) |
|---|---|
| Age | |
| Median in years (IQR) | 63 (52-71) |
| Gender | |
| Male | 51 (35.7) |
| Female | 92 (64.3) |
| Ethnicity | |
| Black | 74 (51.7) |
| Mixed race | 11 (7.7) |
| White | 58 (40.6) |
| Ischaemic heart disease | 30 (21.0) |
| Stroke | 7 (4.9) |
| Cigarette smoking (n = 113) | 12 (10.6) |
| Peripheral vascular disease | 9 (6.3) |
| Hypertension | 131 (91.6) |
| Hypothyroidism | 31 (21.7) |
| Body mass index ≥ 30 kg/m2 (n = 127) | 85 (66.9) |
| Blood pressure | |
| Grade 1 hypertension | 13 (9.1) |
| Grade 2 hypertension | 8 (5.6) |
| Grade 3 hypertension | 9 (6.3) |
| Isolated systolic hypertension | 45 (31.5) |
| Antidiabetic therapy | |
| Oral therapy only | 5 (3.5) |
| Insulin therapy only | 53 (37.1) |
| Dual oral and insulin therapy | 85 (59.4) |
| HbA1ca >7 % | 113 (79.0) |
| Lipid-lowering therapy | |
| Statin only | 135 (94.4) |
| Fibrate only | 3 (2.1) |
| Dual statin and fibrate therapy | 5 (3.5) |
aHbA1c glycated haemoglobin